Found 0 matching trials
Thyroid Cancer and (FDG)PET/CT Scan N/A Background and Rational
(Introduction)
Differentiated thyroid carcinoma (...
Show More Location
Multiple Locations
Learn More & Join Trial
Kidney Uptake at F-18 FDG PET/CT Studies and Renal Function Status N/A Searching for a possible correlation between renal uptake at F-18-FDG PET/C...
Show More Location
Multiple Locations
Learn More & Join Trial
Hepatosplenic CANdidiasis : PETscan and Immune Response Analysis NA The purpose of this study is to determine whether F18 fluorodeoxyglucose (1...
Show More Location
Service des Maladies Infectieuses et Tropicales - Centre d'Infectiologie Necker-Pasteur, IHU Imagine - Hôpital Necker-Enfants Malades,
Learn More & Join Trial
68Ga-FAP-CHX PET/CT : Dosimetry and Preliminary Clinical Translational Studies PHASE1 As an emerging molecule targeting FAP, 68Ga-FAP-CHX is promising as an exce...
Show More Location
Department of Nuclear Medicine, First Affiliated Hospital of Fujian Medical University
Learn More & Join Trial
Fludeoxyglucose F 18-PET Imaging for Early Detection of Residual Disease in Patients Undergoing Radiofrequency Ablation of Liver Metastases From Colorectal Cancer NA RATIONALE: Diagnostic procedures, such as fludeoxyglucose F 18-PET imaging,...
Show More Location
Lineberger Comprehensive Cancer Center at University of North Carolina - Chapel Hill
Learn More & Join Trial
Comparison of PET/CT vs. PET/MRI Using 2 Radiopharmaceuticals PHASE2 This clinical trial studies how well positron emission tomography (PET)/com...
Show More Location
Stanford University, School of Medicine
Learn More & Join Trial
PET Imaging Study of 68Ga-NB381 in Multiple Myeloma EARLY_PHASE1 Multiple myeloma (MM) predominantly affects the elderly, often presenting i...
Show More Location
Peking University First Hospital
Learn More & Join Trial
18F-FDG PET and Osimertinib in Evaluating Glucose Utilization in Patients with EGFR Activated Recurrent Glioblastoma PHASE2 This phase II trial studies how well fludeoxyglucose F-18 (18F-FDG) positro...
Show More Location
UCLA / Jonsson Comprehensive Cancer Center
Learn More & Join Trial
FDG-Labeled PET Scan in Planning Chemotherapy in Treating Patients With Stage IIIB or IV Non-Small Cell Lung Cancer PHASE2 This phase II trial studies how well fludeoxyglucose F 18 (FDG)-labeled pos...
Show More Location
Harborview Medical Center
Learn More & Join Trial
Lu-177-DOTATATE (Lutathera) in Combination With Olaparib in Inoperable Gastroenteropancreatico Neuroendocrine Tumors (GEP-NET) PHASE1 Background:
A neuroendocrine tumor is a rare type of tumor. It comes from ...
Show More Location
National Institutes of Health Clinical Center
Learn More & Join Trial